Post-marketing safety surveillance of the novel muscarinic antipsychotic Xanomeline-Trospium for schizophrenia: A comparative disproportionality analysis against olanzapine based on FAERS data
Author:
Yining Zeng,Xueting Wang,Hao Wu,Xiyue Tan,Ruixia Wang,Yuxia Liu,Junguo Duan
Publication:
Psychiatry Research
Date:
Available online 9 June 2026
© 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.